From: Molecular mechanisms and treatment responses of pulmonary fibrosis in severe COVID-19
 | Pre-DEXA-cohort (n = 67) | DEXA-cohort (n = 124) | p-value |
---|---|---|---|
Age, years | 65 [58–72] | 65 [56–72] | 0.89 |
Sex, male | 50 (75) | 84 (68) | 0.41 |
BMI, kg/m2 | 27.7 [24.9–30.8] | 29.4 [26.2–33.3] | 0.005 |
APACHE II | 15 [12–19] | 16 [13–20] | 0.08 |
Days first COVID-19 signs until ICU admission | 11 [7–13] | 10 [7–12] | 0.46 |
Medical history | |||
 Renal insufficiency | 1 (1) | 3 (2) | 1.00 |
 Metastatic neoplasm | 5 (7) | 2 (2) | 0.053 |
 Immunological insufficiency | 1 (1) | 6 (5) | 0.43 |
 COPD | 6 (9) | 13 (10) | 0.81 |
 Diabetes mellitus | 15 (22) | 32 (26) | 0.73 |
 Hypertension | 33 (49) | 63 (51) | 0.88 |